Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...
More »SEARCH RESULT
Total Matching Records found : 8801
Patents and the law -V Venkatesan
The implementation of Patents Act, as last amended in 2005, raises significant issues of immediate concern to patients across the world. INDIA'S Patents Act has an interesting history. Enacted first in 1911 as the Indian Patents and Designs Act in the colonial era, it primarily addressed the interests of inventors, who did not want their inventions infringed upon by anyone who copied them or adopted the methods used to make them....
More »Delhi: 70 pc schools still flouting Right to Education norms-Subhajit Sengupta
Schools in Delhi are openly flouting the Right to Education norms. The RTE has mandated 25 per cent seats in private schools for economically backward students. But more than 70 per cent schools in the capital couldn't care less. But with the Supreme Court upholding the Act, they may not have a choice any more. The Supreme Court had mandated that all private unaided schools across the country should reserve 25...
More »Rajya Sabha to consider repealing Kapil Sibal’s IT Rules-Shivam Vij
-Kafila.org When the Parliament’s budget session re-opens on April 24, the Rajya Sabha will vote on an annulment motion against the IT Rules promulgated in April 2011 that provide for “intermediaries” to remove the online content they are asked to by anyone. The motion has been moved by P Rajeeve, Rajya Sabha member from the Communist Party of India-Marxist. Speaking on the phone from Thrissur, Rajeeve said, “The IT Rules go against...
More »Question of efficacy -Leena Menghaney
The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »
